{"id":936713,"date":"2026-02-12T18:21:39","date_gmt":"2026-02-12T23:21:39","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/"},"modified":"2026-02-12T18:21:39","modified_gmt":"2026-02-12T23:21:39","slug":"cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/","title":{"rendered":"Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p>FREMONT, Calif., Feb.  12, 2026  (GLOBE NEWSWIRE) &#8212; Cytek Biosciences, Inc. (\u201cCytek Biosciences\u201d or \u201cCytek\u201d) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter and full year 2025 after market close on Thursday, February 26, 2026. The company\u2019s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time to discuss its results, business developments and outlook.<\/p>\n<p>Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at investors.cytekbio.com<\/p>\n<p>\n        <strong>About Cytek Biosciences, Inc.<\/strong><br \/>\n        <br \/>Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented Full Spectrum Profiling\u2122 (FSP<sup>\u00ae<\/sup>) technology. Cytek\u2019s novel approach harnesses the power of information within the entire spectrum of a fluorescent signal to achieve a higher level of multiplexing with precision and sensitivity. Cytek\u2019s platform includes: its core FSP instruments, the Cytek Aurora\u2122, Northern Lights\u2122, Cytek Aurora\u2122 CS and Cytek Aurora\u2122 Evo systems; the Cytek Orion\u2122 reagent cocktail preparation system; the Enhanced Small Particle\u2122 (ESP\u2122) detection technology; the flow cytometers and imaging products under the Amnis<sup>\u00ae<\/sup>\u00a0and Guava<sup>\u00ae<\/sup>\u00a0brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Cytek is headquartered in Fremont, California with offices and distribution channels across the globe. More information about the company and its products is available at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=590h8pq2lXlX_-Op-qbk8RijkAfABKIPKTYEoxqcHFoaLf3aaHTYm-ZphWaMuXS_3h__VjjIT9Ns9PXBrT-CvbOwSKNW9t9EgUaVnrRcnUHm_S_9I6VwMtysyuzOXRzj79Fn6m7LNSu2LkLa_8BvvshyV153e3o-MLWF3GnX0EWg4M7jZ07_18XmV_NPHne6lrjdK2xZDmNKwe4-0xgsXmGN5zJwTy3tJYJ-FX-GxvNCm6h2IYkySggwxmZLGSA6EI08Ij8ME9uHlOAwVOT_uFezo_PRW6hLcjKp2DQzPE-X_ntWx7JmIWCedwNFdYN0z6QdPmdZXrUPkXVoIpHhk2AHHQtFjCW0qIPcMi-WNBScKR7f5lx0RBeNOdWiymHZ3Ypbc52Hu_wfpsEbXFYMa-wsuHkLFjjPt-S6ur9Bg7eyn0KUBRHnVHpcS0dRR_b3ZziKN_vtHGPZ2D0Pk_w0G7mEUbvEw5M_PLSF51H6EFHrTCNzrTYe-0IMgEypVR5On8jOz2dqxKfGqV8nJeWAuLBHlkj-Cq7p0c5GO3mFW5D6qa92edlXMRYCTSLqxxOa8W31_ibZH5VvYA5E9GB39SBABciZFdewPSmqLJvv_qLO2XodEqHcoLh5AvIv_vMA5sDRxv1yKAJe4SZf8Mhxdg==\" rel=\"nofollow\" target=\"_blank\">www.cytekbio.com<\/a>.<\/p>\n<p>Cytek\u2019s products are for research use only and not for use in diagnostic procedures (other than Cytek\u2019s Northern Lights-CLC system and certain reagents, which are available for clinical use only in China and the European Union).<\/p>\n<p>Cytek, Full Spectrum Profiling, FSP, Cytek Aurora, Northern Lights, Enhanced Small Particle, ESP, Cytek Orion, Amnis and Guava are trademarks of Cytek Biosciences, Inc.<\/p>\n<p>In addition to filings with the Securities and Exchange Commission (SEC), press releases, public conference calls and webcasts, Cytek uses its website (www.cytekbio.com), LinkedIn page and X account as channels of distribution of information about its company, products, planned financial and other announcements, attendance at upcoming investor and industry conferences and other matters. Such information may be deemed material information and Cytek may use these channels to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Cytek\u2019s website, LinkedIn page, and X account in addition to following its SEC filings, news releases, public conference calls and webcasts.<\/p>\n<p>\n        <strong>Media Contact:<\/strong><br \/>\n        <br \/>Stephanie Olsen<br \/>Lages &amp; Associates<br \/>(949) 453-8080<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9ykAY3OqSuOdlXH7chuH256OtmR0YMgEYQG13a0BTBFXBwawUQ7WoJS-hgdGXePkMTE1IguHPplP_NObkotQn_WXOLIGhCMqyMSM359jUZA=\" rel=\"nofollow\" target=\"_blank\">stephanie@lages.com<\/a><\/p>\n<p>\n        <strong>Investor Contact:<\/strong><br \/>\n        <br \/>Paul Goodson<br \/>Head of Investor Relations<br \/>Cytek Biosciences<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=r5K8bgj_DYaAi60nTy_IKhdBS0uA8UeqJcdqltpEjPxtZRpnSjdmjXflfkWt4WP-h6j614OXP2YtJgW_rhKPbwOVVq0v6Ysne93vAuBSrd8=\" rel=\"nofollow\" target=\"_blank\">pgoodson@cytekbio.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MjE2MiM3NDE4ODgzIzIwOTU3ODY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YzNlZjI0M2ItZjhiZC00MjM1LTg3OWUtODhkZDQwYTBlMDU4LTExMDczNTctMjAyNi0wMi0xMi1lbg==\/tiny\/Cytek-Biosciences-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>FREMONT, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) &#8212; Cytek Biosciences, Inc. (\u201cCytek Biosciences\u201d or \u201cCytek\u201d) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter and full year 2025 after market close on Thursday, February 26, 2026. The company\u2019s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at investors.cytekbio.com About Cytek Biosciences, Inc. Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-936713","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"FREMONT, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) &#8212; Cytek Biosciences, Inc. (\u201cCytek Biosciences\u201d or \u201cCytek\u201d) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter and full year 2025 after market close on Thursday, February 26, 2026. The company\u2019s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at investors.cytekbio.com About Cytek Biosciences, Inc. Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented &hellip; Continue reading &quot;Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-12T23:21:39+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MjE2MiM3NDE4ODgzIzIwOTU3ODY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026\",\"datePublished\":\"2026-02-12T23:21:39+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\\\/\"},\"wordCount\":441,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MjE2MiM3NDE4ODgzIzIwOTU3ODY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\\\/\",\"name\":\"Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MjE2MiM3NDE4ODgzIzIwOTU3ODY=\",\"datePublished\":\"2026-02-12T23:21:39+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MjE2MiM3NDE4ODgzIzIwOTU3ODY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MjE2MiM3NDE4ODgzIzIwOTU3ODY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/","og_locale":"en_US","og_type":"article","og_title":"Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - Market Newsdesk","og_description":"FREMONT, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) &#8212; Cytek Biosciences, Inc. (\u201cCytek Biosciences\u201d or \u201cCytek\u201d) (Nasdaq: CTKB), today announced it will report financial results for the fourth quarter and full year 2025 after market close on Thursday, February 26, 2026. The company\u2019s management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time \/ 4:30 p.m. Eastern Time to discuss its results, business developments and outlook. Live audio of the webcast will be available on the \u201cInvestors\u201d section of the company website at investors.cytekbio.com About Cytek Biosciences, Inc. Cytek Biosciences (Nasdaq: CTKB) is a leading cell analysis solutions company advancing the next generation of cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its patented &hellip; Continue reading \"Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-12T23:21:39+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MjE2MiM3NDE4ODgzIzIwOTU3ODY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026","datePublished":"2026-02-12T23:21:39+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/"},"wordCount":441,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MjE2MiM3NDE4ODgzIzIwOTU3ODY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/","name":"Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MjE2MiM3NDE4ODgzIzIwOTU3ODY=","datePublished":"2026-02-12T23:21:39+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MjE2MiM3NDE4ODgzIzIwOTU3ODY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MjE2MiM3NDE4ODgzIzIwOTU3ODY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytek-biosciences-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-26-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cytek Biosciences to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/936713","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=936713"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/936713\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=936713"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=936713"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=936713"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}